Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

New Products from the EGAPP Working Group: Further Development of Evidence Review Methodology and More Recommendations in Genomic Medicine

Posted on by Michael P. Douglas and W. David Dotson, Office of Public Health Genomics, Centers for Disease Control and Prevention

The independent EGAPP working group (EWG) held its 27th meeting on May 13-14, 2013 via a virtual online venue. The EWG has been very active since the last meeting.  Highlights included:EGAPP logo

  • The EWG heard a presentation on an ongoing review by the KSC, on MSI status and response to 5FU chemotherapy in Lynch syndrome patients, to consider drafting a recommendation.

In an effort to further the field of evidence-based review processes, the past and present EWG members have submitted a manuscript to Genetics in Medicine entitled, “The EGAPP Initiative:  Lessons Learned” to inform stakeholders of the possibilities and pitfalls of their efforts. Furthermore, the EWG expects to have three additional new recommendations and one to two recommendation updates in the next year.

The next EGAPP Working Group meeting will be held on August 19-20, 2013 in Atlanta, GA.

Posted on by Michael P. Douglas and W. David Dotson, Office of Public Health Genomics, Centers for Disease Control and PreventionTags , ,

Post a Comment

Your email address will not be published. Required fields are marked *

All comments posted become a part of the public domain, and users are responsible for their comments. This is a moderated site and your comments will be reviewed before they are posted. Read more about our comment policy »

TOP